Vision Sensing Acquisition to transfer listing to Nasdaq Capital Market and pursue merger with Mediforum
Acquiring Company
HCM II Acquisition
Acquired Company
Mediforum
District Of Columbia
South KoreaFinancial ServicesVenture CapitalBiotechnologyHealth CareDescription
Vision Sensing Acquisition has announced its intention to transfer its listing to the Nasdaq Capital Market from Nasdaq Global, aiming to pursue a merger with Mediforum, a Seoul-based biomedical company developing treatments for Alzheimer’s and memory enhancement. The merger consideration is $250 million in stock, and if approved, the combined company intends to list on the Nasdaq.
Quick answer
HCM II Acquisition is acquiring Mediforum, announced April 22, 2024. HCM II Acquisition is based in District Of Columbia, United States.
- How much did HCM II Acquisition pay for Mediforum?
- The deal value was not disclosed.
- What does HCM II Acquisition do?
- HCM II Acquisition Corp. is a special-purpose acquisition company.
- Where are HCM II Acquisition and Mediforum based?
- HCM II Acquisition is based in District Of Columbia, United States. Mediforum is based in South Korea.
Source: Fundz verified event record.
Other recent acquisitions in Financial Services and Venture Capital
Deals where the buyer or target shares a sector with this one, within 45 days, from Fundz verified event records.
- Novo Holdings A/S to acquire Catalent, Inc. for $63.50 per share in cash (May 29, 2024)
- Cycle Pharmaceuticals proposes to acquire Vanda Pharmaceuticals for $8.00 per share (June 6, 2024)
- MangoRx Acquires Revolutionary Preventive Care Technology from Intramont Technologies (June 4, 2024)
- Alcanza Clinical Research completes acquisition of North Georgia Clinical Research to enhance research participation opportunities (June 3, 2024)
- Vision Sensing Acquisition extends completion date for $250M Mediforum deal, $250M (May 30, 2024)
- GTCR to acquire Surmodics, Inc. for $627 Million, $627M (May 29, 2024)
Who to call at HCM II Acquisition, and when
When HCM II Acquisition changes hands, the new owners review vendors, systems and leadership. That is when the door opens.
- An alert the day HCM II Acquisition raises, hires an executive or expands, scored against what you sell
- The decision-makers there, with verified emails
- Who you already know at HCM II Acquisition, from your own LinkedIn network
Works inside ChatGPT and Claude. Ask who to call at HCM II Acquisition. With Fundz connected, it knows.
AI made execution free. Knowing first is the whole game now.
Fundz sees it the moment HCM II Acquisition makes an acquisition, hires an exec or expands, usually minutes after it happens, and tells you who to reach.
Frequently asked
Who acquired Mediforum?
Mediforum was acquired by HCM II Acquisition, based in District Of Columbia. The deal was reported on April 22, 2024. HCM II Acquisition Corp. is a special-purpose acquisition company. It focuses on acquiring companies in various industries. The firm aims to support growth for the acquired entities. HCM II Acquisition is privately held and operates in Financial Services.
When did HCM II Acquisition acquire Mediforum?
HCM II Acquisition's acquisition of Mediforum was reported on April 22, 2024. Fundz records the date the transaction was first publicly reported, sourced from filings and company announcements.
What does Mediforum do?
Mediforum, established in 2015, is a biomedical company developing treatments for Alzheimer’s and memory enhancement. It is headquartered in Seoul, South Korea. It is privately held, operating in Biotechnology, and is based in South Korea.
This company was part of an acquisition. Fundz tracks who bought whom, and who to call on both sides.
145 of these a day, filtered to the companies you pick, with the decision-maker attached.
5 screens from a live account. No signup.